Administration of CORM-2 inhibits diabetic neuropathy but does not reduce dyslipidemia in diabetic mice. PLoS ONE

KA Méndez-Lara, D Santos, N Farré, S Ruiz-Nogales, S Leánez, JL Sánchez-Quesada, E Zapico, E Lerma, JC Escolà-Gil, F Blanco-Vaca, JM Martín-Campos, J Julve, O Pol

Research output: Contribution to journalArticleResearch

Original languageEnglish
Pages (from-to)-
JournalPLos ONE 13(10): e0204841.
Volume13
Publication statusPublished - 1 Jan 2018

Cite this